Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Charles Miller, MD, is the Enterprise Director of Cleveland Clinic Transplantation and surgical director of the Liver Transplant program. He is also a Staff Physician in the Department of General Surgery. Liver transplantation and living donation are his areas of special interest. He has had personal involvement in more than 175 living donor liver transplants during his career.
Board-certified in general surgery, Dr. Miller has authored more than 200 manuscripts. He holds many professional memberships both nationally and internationally, including the American College of Surgeons and the International Liver Transplantation Society. Currently, he serves as President for the American Society of Transplant Surgeons.
He is a graduate of The Mount Sinai School of Medicine in New York, N.Y. He completed his surgical residency, a clinical and research fellowship in transplantation as well as a vascular surgery fellowship at Mount Sinai Hospital in New York. Dr. Miller's surgical career continued at Mount Sinai Hospital as the Director of Liver Transplantation and ultimately the Director of the Recanati/Miller Transplantation Institute. He joined the Cleveland Clinic in 2004 as the Program Director for Liver Transplantation.
biliary and pancreatic surgery, hepatitis B.C., hepatobiliary and pancreatic surgery, hepatobiliary surgery, Hepatocellular Carcinoma, immunosuppression, Intestinal transplant and surgery, liver, liver and pancreas transplantation, liver transplantation, liver transplantation in HIV positive patients, living donor liver transplantation, Liver surgery, living donor liver transplantation (duplicate), organ donation, pediatric liver transplant, Portal Hypertension
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 12/9/2016, Dr. Miller has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.